paris saponin vii has been researched along with Bone Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, H; Cheng, G; Gao, F; Sun, X; Zhu, Y | 1 |
1 other study(ies) available for paris saponin vii and Bone Neoplasms
Article | Year |
---|---|
Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Osteosarcoma; Saponins; Trillium | 2016 |